Internal Medicine, Hematology & Oncology · Cincinnati, OH
NPI
1265425078
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4777 E Galbraith Rd, Ste 320
Cincinnati, OH, 45236
Phone (513) 751-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
101,304 services
Medicare patients, 2024
309
Average age 74
Drug cost, 2024
$10.3M
2,308 prescriptions
Company payments, 2025
$13K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James H Essell was code J1568 (injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg), 4,950 times for 25 patients. In total James H Essell billed 101,304 services in 129 codes, and Medicare paid $1.7M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 4,950 | 25 | $36.73 | $182K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,683 | 35 | $0.08 | $139 |
| 85025 Blood Count | Office | 925 | 222 | $7.60 | $7,028 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 820 | 12 | $0.25 | $205 |
| 80053 Clinical Chemistry | Office | 759 | 196 | $10.33 | $7,840 |
| 99214 Office E&M - Established | Office | 706 | 174 | $88.23 | $62K |
| 82784 Immunoassay | Office | 488 | 86 | $9.10 | $4,439 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 477 | 201 | $11.92 | $5,684 |
| 83615 Clinical Chemistry | Office | 341 | 120 | $5.90 | $2,013 |
| 99213 Office E&M - Established | Office | 263 | 159 | $59.52 | $16K |
| 96413 Chemotherapy Administration | Office | 193 | 48 | $78.33 | $15K |
| 96372 Injection Administration | Office | 152 | 39 | $10.06 | $1,529 |
| 96367 Intravenous Infusion, Hydration | Office | 133 | 34 | $17.08 | $2,272 |
| 96365 Intravenous Infusion, Hydration | Office | 116 | 41 | $43.61 | $5,059 |
| 96375 Injection Administration | Office | 109 | 25 | $10.66 | $1,162 |
By year: 2022 $1.8M for 149,728 services; 2023 $2.3M for 125,641 services; 2024 $1.7M for 101,304 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 925 | 222 | $7.60 | $7,028 |
| 80053 Clinical Chemistry | 759 | 196 | $10.33 | $7,840 |
| 82784 Immunoassay | 488 | 86 | $9.10 | $4,439 |
| 83615 Clinical Chemistry | 341 | 120 | $5.90 | $2,013 |
| 82728 Clinical Chemistry | 86 | 44 | $13.36 | $1,149 |
| 83735 Clinical Chemistry | 85 | 23 | $6.57 | $558 |
| 83550 Clinical Chemistry | 72 | 45 | $8.57 | $617 |
| 83540 Clinical Chemistry | 72 | 45 | $6.34 | $456 |
| 84100 Clinical Chemistry | 37 | 20 | $4.65 | $172 |
| 84550 Clinical Chemistry | 24 | 12 | $4.43 | $106 |
Medicare prescription drug claims, 2024
In 2024, the drug James H Essell prescribed most often to Medicare patients was Penicillin V Potassium, with 145 prescriptions and refills. In total James H Essell wrote 2,308 Medicare prescriptions that cost $10.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Penicillin V Potassium Generic | 145 | 235 | 28 | $1,755 |
| Acyclovir Generic | 137 | 173 | 27 | $1,729 |
| Valacyclovir Valacyclovir Hcl | 131 | 181 | 27 | $5,818 |
| Calquence Acalabrutinib Maleate | 95 | 95 | 12 | $1.3M |
| Eliquis Apixaban | 85 | 99 | 15 | $57K |
| Imbruvica Ibrutinib | 83 | 83 | Under 11 | $1.3M |
| Warfarin Sodium Generic | 68 | 122 | 12 | $615 |
| Dexamethasone Generic | 62 | 62 | 18 | $943 |
| Jakafi Ruxolitinib Phosphate | 56 | 56 | Under 11 | $740K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 55 | 69 | 12 | $403 |
| Venclexta Venetoclax | 52 | 52 | Under 11 | $291K |
| Gabapentin Generic | 52 | 65 | Under 11 | $698 |
| Revlimid Lenalidomide | 48 | 48 | Under 11 | $836K |
| Pantoprazole Sodium Generic | 46 | 88 | 13 | $395 |
| Pomalyst Pomalidomide | 43 | 43 | Under 11 | $942K |
Brand drugs: - claims; generic drugs: 1,625 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James H Essell $13K ($13K in general payments such as food, travel and fees) from 14 companies. The largest payer was Genmab U.S., Inc. with $11K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.